Anti-IGF-1R CAR T cells and anti-ROR1 CAR T cells derived from healthy donors showed cytotoxicity against IGF-1R positive and ROR1 positive sarcoma cell lines in vitro, respectively, and were able to release IFN-γ, TNF-α and IL-13 upon antigen stimulation [82]. This evidence concerns the gene IGF1R and sarcoma.